• Abundance International guided for a net profit for the six months ended June 30, 2026, based on draft unaudited results.
• Outlook driven by higher gross margins in its chemical trading business.
• Cost rationalization at Orient-Salt Chemicals operations in China, Japan expected to cut operating expenses.
• Investment arm posted stronger performance, led by realized gains, unrealized fair-value gains versus the six months ended June 30, 2025.
• Condensed interim results targeted for release on or before Aug. 14, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abundance International Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: ABAVNKZD0H5MQK09) on July 28, 2026, and is solely responsible for the information contained therein.